SCHEMBL4037264

SCHEMBL4037264

O=C(NCc1ccc(F)cc1)C1CCNCC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.68
SMN1; SMN2 Q16637 3/20 0.68
TSHR P16473 1/20 0.59
HTR2C P28335 1/20 0.57
CYP3A4 P08684 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
LMNA P02545 1/20 0.55
ERCC1 P07992 1/20 0.55
ERCC4 Q92889 1/20 0.55
SLC13A5 Q86YT5 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
POLB P06746 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
TP53 P04637 1/20 0.53
KDM4E B2RXH2 1/20 0.53
USP2 O75604 1/20 0.53
HPGD P15428 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6479155 0.98 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2TSHRHTR2CCYP3A4
SCHEMBL5081412 0.85 KMT2A (0.59) ALDH1A1SMN1; SMN2L3MBTL1POLBMEN1
SCHEMBL4027409 0.85 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2TSHRHTR2CERCC1
SCHEMBL13746002 0.85 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2TSHRHTR2CCYP3A4
SCHEMBL13745651 0.85 ALDH1A1 (0.72) ALDH1A1SMN1; SMN2TSHRHTR2CCYP3A4
SCHEMBL172079 0.85 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2HTR2CMAPTSLC13A5
SCHEMBL526330 0.84 ALDH1A1 (0.73) ALDH1A1SMN1; SMN2TSHRHTR2CUSP2
SCHEMBL19064907 0.84 ALDH1A1 (0.67) ALDH1A1SMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL25156178 0.84 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2TSHRHTR2CERCC1
SCHEMBL29583269 0.84 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2TSHRHTR2CERCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086462-A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS WYETH (US) 2008-07-17 WO claimed
WO-2012006104-A2 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS INFECTION Academia Sinica, Taiwan (TW) 2012-01-12 WO disclosed
EP-1501467-A4 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL MYERS SQUIBB CO (US) 2009-08-19 EP disclosed
WO-2009098282-A1 LOW MOLECULAR WEIGHT 2,5-DISUBSTITUTED THIOPHENE DERIVATIVES AND USE THEREOF IN THERAPY NOVASAID AB (SE) 2009-08-13 WO disclosed
WO-2008086462-A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS WYETH (US) 2008-07-17 WO disclosed
EP-1501467-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION Bristol-Myers Squibb Company (US) 2005-02-02 EP disclosed
WO-2003088908-A2 HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2003-10-30 WO disclosed